查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1962556

血液采集管机械市场：依操作模式、技术、管型、最终用户和应用划分－全球预测，2026-2032年

Blood Collection Tube Machines Market by Operation Mode, Technology, Tube Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血液采集管製造设备市场价值将达到 7.7137 亿美元，到 2026 年将成长至 8.3067 亿美元，到 2032 年将达到 12.2793 亿美元，复合年增长率为 6.86%。

主要市场统计数据
基准年 2025 7.7137亿美元
预计年份：2026年 8.3067亿美元
预测年份 2032 1,227,930,000 美元
复合年增长率 (%) 6.86%

全面概述影响血液采集管机采购和实施的不断变化的临床、营运和监管因素。

血液采集管处理系统市场处于临床需求、检查室效率和严格监管要求的交汇点，这要求相关人员在处理能力需求与准确性、安全性和可追溯性之间取得平衡。随着检查室自动化技术的进步和对检体完整性的日益重视，能够可靠处理各种类型试管、与实验室资讯系统整合并支援严格的品管流程的设备的重要性日益凸显。随着临床路径朝向分散式和高通量检测方向发展，操作人员必须评估能够平衡效能、拥有成本和供应商服务能力的设备。

对关键变革性技术、供应链和监管趋势进行详细分析，以重新定义产品蓝图和临床部署模式。

近年来，临床采血管装置的规格、製造和应用方式发生了翻天覆地的变化。装置製造商正在将数位感测器和连接功能融入其中，实现装置即时健康诊断、检体追踪以及与实验室资讯系统的集成，从而使装置从单纯的机械功能转变为互联平台。同时，自动化趋势推动了封闭式工作流程的发展，减少了人为接触，提高了生物安全性，使得自动化解决方案在高通量操作中越来越受欢迎。而在资源受限的环境中，半自动化系统仍保持着一定的市场需求。

对新的关税结构如何重塑全球供应链、筹资策略和各行业的製造地地点进行深入调查。

2025年实施的新关税措施引入了新的结构性变量，影响产业的采购经济性、供应链设计和策略采购。关税造成的成本差异迫使製造商重新评估其全球生产地点，并考虑将关键子组件的生产外包到近岸地区，以保持价格竞争力并缩短前置作业时间。因此，买卖双方的谈判越来越多地包含有关关税应急措施、成本转嫁机制以及库存和物流风险共担安排的条款。

策略性细分洞察揭示了操作模式、感测技术、管道配置、最终用户需求和应用如何决定采购和产品设计优先顺序。

市场区隔揭示了不同的需求驱动因素，并明确了每种操作模式、技术类型、管路类型、终端用户环境和临床应用的产品适用性要求。专为自动化操作设计的仪器面向高通量检查室优先考虑最大限度地减少人工干预并与下游分析仪无缝整合。另一方面，半自动仪器在重视灵活手动监控的人员配置模式中，或在资金限制无法投资全自动化的环境中仍然非常重要。机械、光学和压力技术各有优缺点：机械系统在基本灌装检测方面具有稳健性和低复杂性；光学模式可实现非接触式监控和增强的检体检验；压力感测器可快速定量评估管路容积和真空状态。非真空管路和真空管路的选择会影响仪器配置和耗材管理。标准化采样工作流程通常需要真空管路，而非真空管路则用于特殊或资源受限的环境。

从全面的区域观点出发，重点介绍美洲、欧洲、中东和非洲以及亚太市场在采用驱动因素、监管环境和采购行为方面的差异。

区域趋势反映了临床基础设施、管理体制和采购实践方面的差异，这些差异会影响产品应用和商业策略。在美洲，先进的临床检查室和集中式检测网路正在推动对具备强大售后服务和整合能力的高通量自动化系统的需求。该地区重视快速创新週期和数位化医疗的普及，这为优先考虑连接性、分析和生命週期服务的解决方案提供了机会，从而最大限度地提高运作和效率。

深入的企业级分析，着重于透过整合解决方案、卓越服务、伙伴关係和智慧财产权策略来实现差异化。

该行业的竞争动态着重于差异化的产品系列、服务深度以及提供整合工作流程的能力，而非独立设备。领先的製造商凭藉其在与检测设备和资讯系统经过检验的整合、久经考验的现场可靠性以及包括安装、预防性保养和备件物流在内的快速售后服务方面的优势展开竞争。与耗材供应商和契约製造建立策略合作伙伴关係，可以加快新设备型号的上市速度。同时，对感测器技术、样品处理演算法和软体检验等相关智慧财产权的投资，能够建构起可抵御竞争的竞争优势。

为製造商和买家提供可操作且优先考虑的建议，以改善互通性、供应链韧性、服务模式、监管合规性和永续性成果。

产业领导者应推动一系列切实有效的倡议，使产品开发与营运实际情况和买家期望相契合。优先投资于互通性和安全资料交换，并确保设备与实验室资讯系统和下游分析平台无缝集成，将提升高通量检查室和医院网路的价值。同时，应实现製造和筹资策略多元化，以降低关税相关的成本波动风险，并缩短关键零件和备件的前置作业时间。兼顾互联互通和供应链韧性，将有助于减少采购摩擦，并提升长期竞争力。

我们将以透明的方式解释我们的混合方法研究途径，该方法结合了专家访谈、标准审查、供应链映射和检验研讨会，以确保获得可靠的见解。

本调查方法结合了定性和定量技术，旨在全面了解技术、采购和营运环境。调查的第一阶段包括对实验室经理、血库管理人员、医院采购负责人、医疗设备工程师和法规专家进行结构化访谈，以确定实际限制、检验要求和实施重点。第二阶段整合了产品文件、标准文件、临床指南和公开的法规判例，以阐明器械设计选择和上市后义务的背景。

简洁扼要的总结强调了产品完整性、互通性、供应弹性和分阶段部​​署的策略要求，以最大限度地发挥临床影响。

总之，自动化血液采集管处理系统是实现临床诊断、血库、法医学分析和调查应用中安全、高效且可追溯的检体工作流程的关键基础技术。选择合适的系统需要对自动化程度、感测技术、试管相容性、互通性和服务保障进行全面评估。考虑到区域和应用方面的差异，客製化产品和灵活的商业模式对于满足高通量集中式检查室和分散式临床环境的需求至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：市场运作

  • 自动的
  • 半自动

第九章 血液采集管机械市场：依技术划分

  • 机械的
  • 光学的
  • 压力

第十章：按管型分類的采血管机械市场

  • 非真空型
  • 真空型

第十一章 采血管机械市场：依最终用户划分

  • 血库
  • 检查室
  • 医院

第十二章 采血管机械市场：依应用领域划分

  • 临床诊断
  • 法医学
  • 调查

第十三章：采血管机械市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：采血管机械市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 采血管机械市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国采血管机械市场

第十七章：中国采血管机械市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Ajosha Bio Teknik Pvt. Ltd.
  • Becton, Dickinson and Company
  • Biomall
  • Bio-x Diagnostics
  • CDRICH Corporation
  • CML Biotech Ltd.
  • Danaher Corporation
  • Gong Dong Medical
  • GPC Medical, Ltd.
  • Hawach Scientific Co., Ltd.
  • KS Medical
  • Medtronic plc
  • Narang Medical Limited
  • Nipro Corporation
  • Qiagen NV
  • Quantum Biomedicals
  • Roche Holding AG
  • Sanli Medical
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • TUD Corporation
Product Code: MRR-0A38069518BF

The Blood Collection Tube Machines Market was valued at USD 771.37 million in 2025 and is projected to grow to USD 830.67 million in 2026, with a CAGR of 6.86%, reaching USD 1,227.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 771.37 million
Estimated Year [2026] USD 830.67 million
Forecast Year [2032] USD 1,227.93 million
CAGR (%) 6.86%

Comprehensive introduction to the evolving clinical, operational, and regulatory forces shaping procurement and deployment of blood collection tube machines

The blood collection tube machine landscape sits at the intersection of clinical demand, laboratory efficiency, and regulatory rigor, requiring stakeholders to reconcile throughput requirements with precision, safety, and traceability. Advances in laboratory automation and focus on specimen integrity have increased the importance of devices that reliably process a wide range of tube types, integrate with laboratory information systems, and support rigorous quality control workflows. As clinical pathways evolve toward decentralized and high-volume testing, operators must evaluate equipment that balances performance with cost of ownership and vendor service capabilities.

In parallel, manufacturers face intensifying expectations for device interoperability, digital connectivity, and compliance with evolving standards for medical devices and diagnostics. The procurement community now emphasizes lifecycle support, spare parts availability, and validated consumables compatibility as part of total value assessments. Consequently, strategic planning must incorporate operational continuity, supply chain resilience, and the capacity to adapt machines to both established and emergent sample collection protocols. Together, these dynamics shape procurement choices and long-term capital allocation for laboratories, hospitals, and blood banks.

In-depth analysis of major transformative technological, supply chain, and regulatory shifts that are redefining product roadmaps and clinical adoption patterns

Recent years have produced a wave of transformative shifts that alter how blood collection tube machines are specified, manufactured, and adopted across clinical settings. Device makers increasingly embed digital sensors and connectivity to provide real-time diagnostics of device health, sample tracking, and integration with laboratory information systems, moving beyond isolated mechanical functions toward connected platforms. Concurrently, automation trends favor closed workflows that reduce human touchpoints and improve biosafety, making automatic solutions more attractive for high-volume operations while semi-automatic systems retain appeal in constrained-resource environments.

Material innovation and precision engineering have improved compatibility with both vacuum and non-vacuum tube formats, while new sensing modalities-mechanical, optical, and pressure-based-enhance detection of fill volume and clot formation. Sustainability concerns have catalyzed research into recyclable components and reduced single-use waste, prompting manufacturers to rethink consumables and service models. Moreover, geopolitical shifts and supply chain reconfiguration accelerate localization strategies and diversified supplier networks. Regulatory pathways are also adapting to the digitalization of devices, with increased scrutiny on cybersecurity, data integrity, and software validation, which in turn informs product roadmaps and post-market surveillance obligations. Together, these shifts require integrated responses from manufacturers, clinical leaders, and procurement teams.

Thorough exploration of how new tariff structures are reshaping global supply chains, procurement strategies, and manufacturing footprints across the industry

The introduction of new tariff measures in 2025 has introduced another structural variable affecting procurement economics, supply chain design, and strategic sourcing in the industry. Tariff-driven cost differentials have compelled manufacturers to reassess global production footprints and to consider nearshoring for critical subassemblies to preserve competitive pricing and shorten lead times. As a result, buyer-supplier negotiations increasingly include clauses that address tariff contingencies, cost pass-through mechanisms, and joint risk-sharing arrangements for inventory and logistics.

In response, clinical operators and distributors have started to incorporate scenario planning into purchasing cycles, emphasizing supplier diversification and longer inventory horizons for critical spare parts. Contract manufacturers and original equipment manufacturers are evaluating shifts in contractual terms and sourcing strategies to mitigate tariff exposure, including seeking alternative materials, qualifying secondary suppliers, and accelerating investments in automated, scalable manufacturing lines closer to major demand centers. Over time, these adjustments will shape product availability, after-sales support geography, and strategic partnerships across the value chain. While tariffs create near-term cost pressure, they also stimulate structural adaptation that can enhance resilience and foster regional manufacturing ecosystems over the longer term.

Strategic segmentation insights revealing how operation modes, sensing technologies, tube formats, end-user needs, and applications determine procurement and product design priorities

Segmentation reveals differentiated demand drivers and distinct product-fit requirements across operation modes, technology types, tube formats, end-user environments, and clinical applications. Devices designed for automatic operation target high-throughput laboratories that prioritize minimal manual intervention and seamless integration with downstream analyzers, while semi-automatic machines retain importance where staffing models favor flexible manual oversight and where capital expenditure constraints limit full automation investments. Mechanical, optical, and pressure-based technologies each present trade-offs: mechanical systems offer robustness and lower complexity for basic fill detection, optical modalities enable non-contact monitoring and enhanced sample verification, and pressure sensors provide rapid, quantitative assessment of tube fill and vacuum integrity. The choice between non-vacuum and vacuum tube types affects device configuration and consumables handling, with vacuum tubes often demanded for standardized collection workflows and non-vacuum formats used in specialized or resource-limited settings.

End users demonstrate varied priorities that influence procurement criteria. Blood banks emphasize chain-of-custody, sample integrity, and biocontainment features, diagnostic laboratories prioritize throughput, automation compatibility, and data integration, while hospitals balance clinical flexibility with bedside workflow constraints and infection control considerations. Application contexts further refine requirements: clinical diagnostics demand rigorous validation and consistent throughput, forensic applications require enhanced traceability and tamper-evidence, and research environments favor modularity and adaptability for diverse study protocols. Understanding these segmentation axes enables vendors and purchasers to align product capabilities with operational needs, craft differentiated value propositions, and prioritize development roadmaps that meet the nuanced expectations of each customer cohort.

Comprehensive regional perspectives highlighting divergent adoption drivers, regulatory landscapes, and procurement behaviors across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics reflect differing clinical infrastructures, regulatory regimes, and procurement behaviors that influence product adoption and commercial strategies. In the Americas, advanced clinical laboratories and centralized testing networks drive demand for high-throughput automatic systems with strong after-sales support and integration capabilities. The region's emphasis on rapid innovation cycles and digital health adoption creates opportunities for solutions that emphasize connectivity, analytics, and lifecycle services to maximize uptime and efficiency.

Across Europe, the Middle East and Africa, stakeholders face a mosaic of regulatory frameworks and funding models that favor versatile solutions able to comply with stringent standards in some markets while remaining cost-effective in others. Public health institutions and centralized reference labs in parts of this region demand validated systems that align with national screening and blood safety programs, while emerging markets within the region require durable, low-maintenance machines suited to constrained operational environments.

In the Asia-Pacific region, rapid healthcare infrastructure expansion and strong manufacturing ecosystems combine with cost-conscious procurement to create a dual dynamic of accelerating adoption and fierce price competition. Hospitals and diagnostic laboratories in major urban centers seek advanced automation and digital features, whereas remote and regional facilities prioritize robustness, serviceability, and simplified operation. Together, these regional trends guide manufacturers in tailoring distribution models, local service footprints, and product feature sets to meet heterogeneous demand profiles.

Insightful company-level analysis focusing on differentiation through integrated solutions, service excellence, partnerships, and intellectual property strategies

Competitive dynamics in the sector center on differentiated product portfolios, service depth, and the ability to deliver integrated workflows rather than standalone equipment. Leading manufacturers compete on the strength of validated integrations with laboratory analyzers and information systems, demonstrated field reliability, and responsive aftermarket services including installation, preventive maintenance, and spare parts logistics. Strategic alliances with consumable suppliers and contract manufacturers enable faster time-to-market for new device variants, while investments in intellectual property around sensor technologies, sample handling algorithms, and software validation create defensible positions.

Smaller and niche players find avenues to compete through targeted innovation, such as specialized modules for forensic traceability or research-grade configurability, and by offering flexible commercial models like pay-per-use service agreements and bundled consumable subscriptions. Mergers and partnerships continue to shape the competitive landscape as firms seek complementary capabilities in digital health, manufacturing scale, or geographic reach. Ultimately, long-term competitiveness depends on the ability to combine product performance, digital services, certified quality systems, and a resilient supply chain to meet the evolving priorities of clinical and laboratory customers.

Practical and prioritized recommendations for manufacturers and buyers to enhance interoperability, supply chain resilience, service models, regulatory readiness, and sustainability outcomes

Industry leaders should pursue a set of pragmatic, high-impact actions that align product development with operational realities and buyer expectations. Prioritize investments in interoperability and secure data exchange to ensure devices integrate smoothly with laboratory information systems and downstream analytics platforms, which enhances value for high-throughput laboratories and hospital networks. Simultaneously, diversify manufacturing and sourcing strategies to reduce exposure to tariff-related cost volatility and to shorten lead times for critical components and spare parts. This dual focus on connectivity and supply resilience will reduce procurement friction and improve long-term competitiveness.

Adopt service-led commercial models that bundle preventive maintenance, validated consumables, and rapid-response field support, thereby shifting customer conversations from upfront cost to predictable total cost of ownership. Develop modular product architectures that allow rapid reconfiguration between vacuum and non-vacuum tube workflows and that accommodate mechanical, optical, or pressure sensing modules according to end-user needs. Engage proactively with regulatory bodies to clarify expectations for software validation, cybersecurity, and post-market surveillance; early alignment reduces time-to-adoption and mitigates compliance risk. Finally, commit to sustainability initiatives that reduce single-use waste and demonstrate supplier transparency, because environmental performance increasingly influences procurement decisions in both public and private sectors.

Transparent description of the mixed-methods research approach combining expert interviews, standards review, supply chain mapping, and validation workshops to ensure robust findings

The research approach blended qualitative and quantitative techniques to produce a comprehensive view of the technology, procurement, and operational landscapes. Primary research included structured interviews with laboratory directors, blood bank managers, hospital procurement officers, device engineers, and regulatory experts to surface practical constraints, validation requirements, and deployment preferences. Secondary analysis incorporated product literature, standards documentation, clinical guidelines, and publicly available regulatory rulings to contextualize device design choices and post-market obligations.

Data triangulation ensured that insights reflected convergent evidence from multiple sources, including device specification comparisons, warranty and service contract analyses, and supply chain mapping exercises. Validation workshops with subject-matter experts refined conclusions and highlighted practical deployment considerations such as installation footprint, consumables logistics, and training needs. Limitations of the methodology include spatial variability in regulatory enforcement and the evolving nature of digital health standards; therefore, stakeholders should treat findings as a strategic guide and complement them with targeted local validations and pilot implementations where appropriate. The research process followed rigorous documentation and reproducibility practices to support client-specific customization requests.

Concise concluding synthesis emphasizing strategic imperatives for product alignment, interoperability, supply resilience, and phased deployment to maximize clinical impact

In summary, blood collection tube machines constitute a critical enabler of safe, efficient, and traceable specimen workflows across clinical diagnostics, blood banking, forensic analysis, and research applications. Device selection now requires a nuanced assessment that balances automation level, sensing technology, tube compatibility, interoperability, and service assurance. Regional and application-specific differences underscore the importance of tailored product offerings and flexible commercial models that address both high-volume centralized laboratories and decentralized clinical environments.

Looking ahead, manufacturers and procurement teams that align product development with digital integration, regulatory expectations, and resilient supply chain strategies will be best positioned to meet evolving clinical needs. Proactive engagement on sustainability and lifecycle support will also create competitive differentiation. Decision-makers should prioritize pilots and phased rollouts to validate interoperability, staff training, and consumables logistics before scaling deployments, thereby minimizing operational disruption and maximizing clinical value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Tube Machines Market, by Operation Mode

  • 8.1. Automatic
  • 8.2. Semi Automatic

9. Blood Collection Tube Machines Market, by Technology

  • 9.1. Mechanical
  • 9.2. Optical
  • 9.3. Pressure

10. Blood Collection Tube Machines Market, by Tube Type

  • 10.1. Non Vacuum
  • 10.2. Vacuum

11. Blood Collection Tube Machines Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals

12. Blood Collection Tube Machines Market, by Application

  • 12.1. Clinical Diagnostics
  • 12.2. Forensic
  • 12.3. Research

13. Blood Collection Tube Machines Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Collection Tube Machines Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Collection Tube Machines Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Blood Collection Tube Machines Market

17. China Blood Collection Tube Machines Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Ajosha Bio Teknik Pvt. Ltd.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Biomall
  • 18.9. Bio-x Diagnostics
  • 18.10. CDRICH Corporation
  • 18.11. CML Biotech Ltd.
  • 18.12. Danaher Corporation
  • 18.13. Gong Dong Medical
  • 18.14. GPC Medical, Ltd.
  • 18.15. Hawach Scientific Co., Ltd.
  • 18.16. KS Medical
  • 18.17. Medtronic plc
  • 18.18. Narang Medical Limited
  • 18.19. Nipro Corporation
  • 18.20. Qiagen N.V.
  • 18.21. Quantum Biomedicals
  • 18.22. Roche Holding AG
  • 18.23. Sanli Medical
  • 18.24. Siemens Healthineers AG
  • 18.25. Sysmex Corporation
  • 18.26. Thermo Fisher Scientific Inc.
  • 18.27. TUD Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SEMI AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SEMI AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SEMI AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY NON VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY NON VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY NON VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY FORENSIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY FORENSIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY FORENSIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)